New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol

Risultato della ricerca: Article

33 Citazioni (Scopus)

Abstract

Drug design was performed through the Virtual Lock-and-Key (VLAK) protocol. This in silico approach allowed to select new annelated thienotriazolopyrimidine derivs., potentially antitumor drugs. Starting from benzothieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidine and pyrido[3',2':4,5]thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidine core structures, new derivs. of these nuclei were designed and synthesized. Three of them were selected by the Development Therapeutical Program (DTP) of the National Cancer Institute (NCI) for the anticancer screening against a panel of 60 human tumor cell lines. The biol. results showed that the new derivs. exhibited an excellent antiproliferative activity reaching sub-micromolar concn. Moreover, to be evidenced their low toxicity and high potency.
Lingua originaleEnglish
pagine (da-a)416-424
Numero di pagine9
RivistaEuropean Journal of Medicinal Chemistry
Volume62
Stato di pubblicazionePublished - 2013

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Fingerprint Entra nei temi di ricerca di 'New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol'. Insieme formano una fingerprint unica.

  • Cita questo